Japanese Clinical Medicine · 2013 · 19 citations · 3 references
MedicineEndocrinologyInternal MedicineClinical EpidemiologyDiabetologyMedical MicrobiologyDiabetes ControlDiabetes ManagementDiabetes MellitusGlycemic ControlHelicobacter Pylori Eradication TherapyEradicationHelicobacter Pylori EradicationHelicobacter Pylori InfectionPathogenic EffectsSubjects
Since infection with Helicobacter pylori has been suggested to play a pathogenic role in diabetes mellitus, we investigated whether eradication therapy for H. pylori might affect glycemic control in Japanese subjects with type 2 diabetes. A total of 72 subjects (55 males, 17 females; aged 63.7 years) with type 2 diabetes who received eradication therapy for H. pylori were included. The change of their blood glycosylated hemoglobin (A1C) levels 3 months before (-3 m) the H. pylori eradication, as well as 3 months (3 m) and 6 months (6 m) after were evaluated. Their A1C levels did not show any significant change after therapy {6.9 [0.1]% (-3 m) to 7.0 [0.1]% (3 m); P = 0.3, 7.0 [0.1] (6 m); P = 0.3}. Our findings suggest that the eradication therapy for H. pylori does not, at least profoundly, affect glycemic control in Japanese subjects with type 2 diabetes.
3
Eradication of insulin resistance
Junta Imai, Tetsuya Yamada, Tokuo Saito et al. · The Lancet · 2009 · 34 citations